Prevnar 20 is the newest pneumococcal conjugate vaccine, offering protection against 20 strains of Streptococcus pneumoniae—a leading cause of pneumonia, meningitis, and bloodstream infections. By covering more strains than previous conjugate vaccines, Prevnar 20 provides one of the broadest available defenses against pneumococcal disease.
- Protection:
- Targets 20 different pneumococcal strains, including those responsible for most severe and antibiotic-resistant infections.
- Provides long-lasting immunity with a single dose for most adults.
- Because of its wide coverage, many individuals may not require an additional pneumococcal vaccine after receiving Prevnar 20.
- Who should receive it:
- Adults 65 years and older – strongly recommended to reduce the risk of pneumonia and invasive pneumococcal disease.
- Adults younger than 65 with certain chronic health conditions, including:
- Diabetes
- Heart disease
- Chronic lung disease (COPD, asthma)
- Chronic liver disease or alcoholism
- Conditions that weaken the immune system (e.g., cancer treatment, HIV, organ transplant recipients).
- Dosage guidance:
- For most adults, one dose provides lifetime protection.
- May replace the need for receiving both Prevnar 13 and Pneumovax 23 in the same vaccination series.
- A healthcare provider will determine whether additional pneumococcal vaccination is needed based on prior vaccination history.
- Why it matters:
- Pneumococcal disease remains a major cause of serious illness, hospitalization, and death, especially among older adults and people with chronic conditions.
- Prevnar 20 simplifies protection by covering more strains in a single dose, offering convenience along with strong immune defense.
To Get Vaccinated – Walk Right In!
No appointments necessary.
We accept WALK-INS until one hour before closing.
Save time by filling out our INTAKE FORM in advance, then bring it with you when you come in.
